236 related articles for article (PubMed ID: 12590952)
1. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects.
Kudolo GB; Dorsey S; Blodgett J
Thromb Res; 2002 Nov; 108(2-3):151-60. PubMed ID: 12590952
[TBL] [Abstract][Full Text] [Related]
2. The ingestion of Ginkgo biloba extract (EGb 761) inhibits arachidonic acid-mediated platelet aggregation and thromboxane B2 production in healthy volunteers.
Kudolo GB; Wang W; Barrientos J; Elrod R; Blodgett J
J Herb Pharmacother; 2004; 4(4):13-26. PubMed ID: 15927922
[TBL] [Abstract][Full Text] [Related]
3. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
Kudolo GB
J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
[TBL] [Abstract][Full Text] [Related]
4. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Rosenkranz B; Fischer C; Meese CO; Frölich JC
Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
Graff J; Skarke C; Klinkhardt U; Watzer B; Harder S; Seyberth H; Geisslinger G; Nüsing RM
J Thromb Haemost; 2007 Dec; 5(12):2376-85. PubMed ID: 17916229
[TBL] [Abstract][Full Text] [Related]
6. Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects.
Kudolo GB; Delaney D; Blodgett J
Diabetes Res Clin Pract; 2005 Apr; 68(1):29-38. PubMed ID: 15811563
[TBL] [Abstract][Full Text] [Related]
7. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
8. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
9. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
Alessandrini P; McRae J; Feman S; FitzGerald GA
N Engl J Med; 1988 Jul; 319(4):208-12. PubMed ID: 3292913
[TBL] [Abstract][Full Text] [Related]
11. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients.
Pancera P; Arosio E; Minuz P; Pirante F; Ribul M; Lechi A
Prostaglandins Leukot Essent Fatty Acids; 1996 Mar; 54(3):217-22. PubMed ID: 8860111
[TBL] [Abstract][Full Text] [Related]
12. Effects of a small dose of ethanol and calcium carbimide-induced acetaldehyde intoxication on human platelet aggregation, associated thromboxane formation and urinary excretion of 2,3-dinor-6-keto prostaglandin F1 alpha.
Neiman J; Hillbom M; Jones AW; Benthin G; Löwbeer C; Sippel H
J Toxicol Clin Toxicol; 1987; 25(3):185-98. PubMed ID: 3612897
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts.
Koch E
Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Vainio M; Riutta A; Koivisto AM; Mäenpää J
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
[TBL] [Abstract][Full Text] [Related]
15. Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites.
Arnaud J; Bost M; Vitoux D; Labarère J; Galan P; Faure H; Hercberg S; Bordet JC; Roussel AM; Chappuis P;
J Am Coll Nutr; 2007 Oct; 26(5):405-11. PubMed ID: 17914127
[TBL] [Abstract][Full Text] [Related]
16. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.
Inui Y; Suehiro T; Kumon Y; Hashimoto K
J Atheroscler Thromb; 1994; 1(2):108-12. PubMed ID: 9222878
[TBL] [Abstract][Full Text] [Related]
17. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
Leonhardt A; Busch C; Schweer H; Seyberth HW
Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
[TBL] [Abstract][Full Text] [Related]
18. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
[TBL] [Abstract][Full Text] [Related]
19. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
[TBL] [Abstract][Full Text] [Related]
20. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
